Makoto Kuroda Selected Research

Makoto Kuroda Research Topics

Disease

26	Infections 01/2022 - 05/2002
26	Neoplasms (Cancer) 01/2021 - 01/2002
6	COVID-19 02/2022 - 01/2020
4	Virus Diseases (Viral Diseases) 02/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 10/2011 - 01/2002
3	Ebola Hemorrhagic Fever 11/2020 - 01/2012
3	Filoviridae Infections 11/2020 - 11/2013
3	Wounds and Injuries (Trauma) 01/2020 - 07/2017
3	Stomach Neoplasms (Stomach Cancer) 05/2018 - 01/2017
3	Carcinoma (Carcinomatosis) 09/2017 - 05/2010
3	Hepatocellular Carcinoma (Hepatoma) 02/2011 - 03/2007
3	Adenocarcinoma 05/2010 - 01/2002
2	Pneumonia (Pneumonitis) 02/2022 - 10/2015
2	Reinfection 01/2022 - 10/2021
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2014
2	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Vesicular Stomatitis 11/2020 - 12/2014
2	Human Influenza (Influenza) 10/2020 - 01/2010
2	Progressive Multifocal Leukoencephalopathy 01/2020 - 01/2017
2	Tuberculosis (Tuberculoses) 01/2019 - 01/2019
2	Epstein-Barr Virus Infections 07/2018 - 01/2017
2	Fever (Fevers) 01/2018 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2013
2	Adenocarcinoma of Lung 09/2017 - 05/2010
2	Ulcerative Colitis 07/2017 - 08/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 02/2017 - 01/2014
2	Inflammation (Inflammations) 01/2017 - 01/2015
2	Abscess 01/2017 - 05/2012
2	Lymphoma (Lymphomas) 01/2017 - 01/2016
2	Ulcer 06/2015 - 01/2002
2	Anthrax 01/2015 - 08/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2014 - 05/2010
2	Disease Progression 01/2012 - 11/2010
2	Thymoma (Thymic Carcinoma) 04/2011 - 07/2008
2	Crigler-Najjar Syndrome 09/2004 - 05/2004
2	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 09/2004 - 02/2004
2	Hyperbilirubinemia 09/2004 - 04/2002
2	Jaundice (Icterus) 05/2004 - 02/2004
1	Sepsis (Septicemia) 12/2021
1	Takotsubo Cardiomyopathy 10/2021
1	Viremia 01/2021
1	Relapsing Fever 01/2021
1	Lung Diseases (Lung Disease) 12/2020
1	Severe Acute Respiratory Syndrome 10/2020
1	Suppuration 01/2020
1	Fistula 01/2020

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 02/2022 - 01/2012
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
7	AntibodiesIBA 10/2021 - 02/2011
6	Pharmaceutical PreparationsIBA 02/2022 - 07/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2010
5	Antiviral Agents (Antivirals)IBA 02/2022 - 06/2015
5	Monoclonal AntibodiesIBA 02/2022 - 01/2012
5	Neutralizing AntibodiesIBA 01/2022 - 01/2012
5	AntigensIBA 01/2021 - 01/2007
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 05/2018 - 01/2015
4	BilirubinIBA 09/2004 - 04/2002
3	N-(2-cyanoethylene)urea (BA 1)IBA 02/2022 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2010
3	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2002
3	human ERBB2 proteinIBA 01/2021 - 10/2020
3	Glycoproteins (Glycoprotein)IBA 11/2020 - 11/2013
3	Immunoglobulin G (IgG)IBA 01/2018 - 12/2013
3	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 01/2017
2	nirmatrelvirIBA 02/2022 - 01/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 02/2022 - 01/2022
2	COV2-2130IBA 02/2022 - 01/2022
2	molnupiravirIBA 02/2022 - 01/2022
2	COV2-2196IBA 02/2022 - 01/2022
2	favipiravirIBA 02/2022 - 10/2020
2	Nucleic AcidsIBA 12/2021 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2021
2	Estrogen ReceptorsIBA 01/2021 - 01/2021
2	InterferonsIBA 11/2020 - 04/2004
2	Immunoglobulin M (IgM)IBA 09/2019 - 01/2018
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 02/2011
2	Anti-Infective Agents (Microbicides)IBA 01/2018 - 01/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 05/2016 - 06/2011
2	Capsules (Microcapsules)IBA 10/2015 - 02/2011
2	N-nitroso-N-methyl-4-nitroanilineIBA 04/2011 - 07/2008
1	GS-441524IBA 02/2022
1	mRNA VaccinesIBA 01/2022
1	ChemokinesIBA 10/2021
1	COVID-19 VaccinesIBA 10/2021
1	CytokinesIBA 10/2021
1	IgG Receptors (Fc gamma RI)IBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021
1	A-factor (Streptomyces)IBA 01/2021
1	Propidium (Propidium Iodide)IBA 01/2021
1	AerosolsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	SulfonamidesIBA 11/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2002
3	Lasers (Laser) 11/2019 - 07/2017
3	Drug Therapy (Chemotherapy) 10/2011 - 01/2002
2	Pancreaticoduodenectomy 01/2020 - 01/2004